Avid and Harmonic Sign Global Patent Licensing Agreement, Settle Litigation
Oct 30, 2017 20:10 pm UTC| Business
BURLINGTON, Mass., Oct. 30, 2017 -- Avid® (Nasdaq:AVID) today announced a global patent cross-licensing agreement with Harmonic Inc. (Nasdaq:HLIT), ending its patent infringement litigation against Harmonic on a...
Texas Roadhouse, Inc. Announces Third Quarter 2017 Results
Oct 30, 2017 20:07 pm UTC| Business
LOUISVILLE, Ky., Oct. 30, 2017 -- Texas Roadhouse, Inc. (Nasdaq:TXRH), today announced financial results for the 13 and 39 week periods ended September 26, 2017. Third Quarter Year to Date($000's) 2017 2016%...
RigNet Names Brad Eastman as SVP and General Counsel
Oct 30, 2017 20:06 pm UTC| Business
HOUSTON, Oct. 30, 2017 -- RigNet, Inc. (NASDAQ:RNET) announced today that Brad Eastman will join the executive management team as Senior Vice President and General Counsel, effective immediately and will report to...
Altra Industrial Motion Corp. to Present at Stephens 2017 Fall Investment Conference
Oct 30, 2017 20:06 pm UTC| Business
BRAINTREE, Mass., Oct. 30, 2017 -- Altra Industrial Motion Corp. (Nasdaq:AIMC), a global manufacturer and marketer of electromechanical power transmission and motion control products, today announced that management...
Cray Inc. Reports Third Quarter 2017 Financial Results
Oct 30, 2017 20:05 pm UTC| Business
SEATTLE, Oct. 30, 2017 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) today announced financial results for its third quarter ended September 30, 2017. All figures in this release are based on U.S. GAAP unless...
Everi Reports 2017 Third Quarter Results and Announces Intent to Reprice Term Loan
Oct 30, 2017 20:05 pm UTC| Business
Q3 Revenues of $247.3 Million, Net Loss of $4.3 Million and Adjusted EBITDA of $53.2 Million Company Intends to Reprice $820 Million Senior Secured Term Loan; Evaluating Opportunities to Refinance $350 Million 10% Senior...
Nightstar Therapeutics to Participate in Multiple Conferences in November
Oct 30, 2017 20:05 pm UTC| Business
LEXINGTON, Mass. and LONDON, Oct. 30, 2017 -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced that the company...